Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndine Biomed Share News (OBI)

Share Price Information for Ondine Biomed (OBI)

Share Price is delayed by 15 minutes
Get Live Data
14.75    0.00 (0.00%)
Bid:
14.50
Ask:
15.00
Spread: 0.50 (3.448%)
Market Cap: £76.63m
OBI Live PriceLast checked at - London Stock Exchange

Intraday Ondine Biomed Share Chart

Ondine Biomed News

AIM WINNERS & LOSERS: Ondine Biomedical rises, Proton Power declines
30 Dec 2024

AIM WINNERS & LOSERS: Ondine Biomedical rises, Proton Power declines

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

Ondine enrols first patient in phase three clinical trial
30 Dec 2024

Ondine enrols first patient in phase three clinical trial

(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surg...

Ondine enrols first patient in phase three clinical trial
30 Dec 2024

Ondine enrols first patient in phase three clinical trial

(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surg...

Ondine Biomedical reports "exciting milestone" in US phase 3 trial
30 Dec 2024

Ondine Biomedical reports "exciting milestone" in US phase 3 trial

(Alliance News) - Ondine Biomedical Inc on Monday said it has recruited and treated the first patient in its phase 3 clinical trial evaluating its non...

Ondine Biomedical to start phase three Steriwave clinical trial
17 Dec 2024

Ondine Biomedical to start phase three Steriwave clinical trial

(Sharecast News) - Ondine Biomedical announced on Tuesday that it would begin its phase three 'LANTERN' clinical trial for its novel nasal photodisinf...

AIM WINNERS & LOSERS: Emmerson up as seeks compensation from Morocco
1 Nov 2024

AIM WINNERS & LOSERS: Emmerson up as seeks compensation from Morocco

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

Ondine raising £8.5m to fund US clinical trial
1 Nov 2024

Ondine raising £8.5m to fund US clinical trial

(Sharecast News) - Ondine Biomedical announced a proposed minimum £8.5m fundraising through a placing and subscription of new shares on Friday, p...

Ondine Biomedical shares climb as raises funds for US clinical study
1 Nov 2024

Ondine Biomedical shares climb as raises funds for US clinical study

(Alliance News) - Ondine Biomedical Inc on Friday revealed a proposed fundraise as it looks to fund a phase 3 clinical study in the US.